Elanco Animal Health Incorporated ELAN
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 152.94% | 390.91% | -14.93% | -3,350.00% | -109.34% |
| Total Depreciation and Amortization | 1.79% | 2.48% | 9.21% | 9.09% | 5.00% |
| Total Amortization of Deferred Charges | -25.00% | -25.00% | -33.33% | -40.00% | -20.00% |
| Total Other Non-Cash Items | 188.89% | 460.00% | 840.00% | 57.14% | 102.90% |
| Change in Net Operating Assets | -152.54% | -53.85% | -10.97% | 301.79% | -76.21% |
| Cash from Operations | -1.37% | 16.88% | 425.00% | -38.98% | 35.19% |
| Capital Expenditure | 34.78% | 42.11% | 21.54% | -31.91% | -119.05% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -100.00% |
| Other Investing Activities | 77.78% | -200.00% | -350.00% | 0.00% | -12.50% |
| Cash from Investing | 38.61% | -96.43% | -3.45% | 28.89% | -108.12% |
| Total Debt Issued | -100.00% | -- | -- | -- | -17.14% |
| Total Debt Repaid | -14.36% | 72.42% | 91.01% | -5,444.74% | 88.82% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | 0.00% | -161.54% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -100.00% | -114.29% | -383.33% | -3,087.50% |
| Cash from Financing | -41.18% | 52.56% | -225.00% | 43.75% | 88.58% |
| Foreign Exchange rate Adjustments | -400.00% | -66.67% | -117.24% | 118.18% | -87.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -91.18% | 96.15% | -715.79% | 281.82% | -145.95% |